Gibraltar Capital Management, Inc. Novartis Ag Transaction History

Gibraltar Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 11, 2022	SELL	$80.11 - $90.62 $496,521 - $561,662	-6,198 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$79.7 - $88.13 $44,632 - $49,352	-560 Reduced 8.29%	6,198 $542,000
Q3 2021 Oct 13, 2021	SELL	$81.78 - $95.14 $4,252 - $4,947	-52 Reduced 0.76%	6,758 $553,000
Q2 2021 Jul 13, 2021	BUY	$85.24 - $94.15 $4,858 - $5,366	57 Added 0.84%	6,810 $629,000
Q1 2021 Apr 20, 2021	BUY	$83.5 - $98.47 $563,875 - $664,967	6,753 New	6,753 $581,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Gibraltar Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Gibraltar Capital Management, Inc. with notifications on news.